Motion Sickness

Mar 02, 2026

Summary The U.S. FDA approved Vanda Pharmaceuticals’ BYSANTI (milsaperidone) for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder. BYSANTI is built on the pharmacologic framework of FANAPT (iloperidone). Vanda’s stock surged nearly 40% after BYSANTI’s approval,...

Oct 06, 2023

There has been an unprecedented explosion in travel in recent years as a result of greater affordability and opportunities. Comfort has become an important element of travel with products such as pillows, eyeshades, and noise-cancelling headphones promising better sleep and reduced stress. Despite these, some peopl...